Characteristic | Fasting | Nonfasting |
Mean age (y) | 73 (52–84) | 71 (53–83) |
Mean weight (kg) | 83 (44–112) | 86 (64–118) |
Mean height (m) | 1.78 (1.60–1.96) | 1.79 (1.68–1.97) |
Mean body mass index (kg/m2) | 26 (16–33) | 27 (20–34) |
Median dose (MBq) | 321 (242–369) | 320 (250–367) |
Median prostate-specific antigen | 57.4 (0.1–1,481) | 40.6 (0.2–500) |
Indication (n) | ||
Primary staging | 16 | 11 |
Biochemical recurrence | 22 | 33 |
Follow-up of systemic therapies | 8 | 5 |
Other | 4 | 1 |
Data in parentheses are range.